Cytokinetics, Incorporated (Form: 8-K)

Cytokinetics (CYTK)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

Annual Reports

Quarterly Reports

8-K

8-K (Nov 6, 2017)8-K (Oct 31, 2017)8-K (Oct 26, 2017)8-K (Sep 19, 2017)8-K (Aug 2, 2017)8-K (Jul 27, 2017)8-K (Jul 5, 2017)8-K (Jun 29, 2017)8-K (May 19, 2017)8-K (May 15, 2017)8-K (May 9, 2017)8-K (Apr 27, 2017)8-K (Apr 4, 2017)8-K (Mar 29, 2017)8-K (Mar 23, 2017)8-K (Mar 22, 2017)8-K (Mar 20, 2017)8-K (Mar 2, 2017)8-K (Feb 16, 2017)8-K (Feb 2, 2017)8-K (Dec 12, 2016)8-K (Dec 9, 2016)8-K (Dec 7, 2016)8-K (Dec 5, 2016)8-K (Dec 1, 2016)8-K (Nov 23, 2016)8-K (Oct 27, 2016)8-K (Oct 18, 2016)8-K (Sep 29, 2016)8-K (Sep 19, 2016)8-K (Sep 8, 2016)8-K (Sep 1, 2016)8-K (Aug 17, 2016)8-K (Jul 28, 2016)8-K (Jul 27, 2016)8-K (May 23, 2016)8-K (May 20, 2016)8-K (Apr 28, 2016)8-K (Apr 4, 2016)8-K (Feb 25, 2016)8-K (Feb 16, 2016)8-K (Feb 12, 2016)8-K (Jan 11, 2016)8-K (Jan 4, 2016)8-K (Nov 16, 2015)8-K (Nov 9, 2015)8-K (Oct 29, 2015)8-K (Oct 27, 2015)8-K (Oct 19, 2015)8-K (Sep 4, 2015)8-K (Jul 29, 2015)8-K (Jul 14, 2015)8-K (May 21, 2015)8-K (Apr 30, 2015)8-K (Mar 13, 2015)8-K (Mar 2, 2015)8-K (Feb 12, 2015)8-K (Feb 10, 2015)8-K (Dec 23, 2014)8-K (Dec 5, 2014)8-K (Oct 30, 2014)8-K (Oct 27, 2014)8-K (Oct 20, 2014)8-K (Oct 14, 2014)8-K (Jul 30, 2014)8-K (Jul 10, 2014)8-K (Jun 13, 2014)8-K (Jun 2, 2014)8-K (May 23, 2014)8-K (May 21, 2014)8-K (May 6, 2014)8-K (Apr 29, 2014)8-K (Apr 25, 2014)8-K (Mar 28, 2014)8-K (Mar 27, 2014)8-K (Feb 27, 2014)8-K (Feb 20, 2014)8-K (Feb 19, 2014)8-K (Feb 6, 2014)8-K (Jan 13, 2014)8-K (Dec 10, 2013)8-K (Dec 3, 2013)8-K (Oct 30, 2013)8-K (Sep 23, 2013)8-K (Aug 22, 2013)8-K (Jul 31, 2013)8-K (Jul 23, 2013)8-K (Jul 8, 2013)8-K (Jun 25, 2013)8-K (Jun 18, 2013)8-K (Jun 12, 2013)8-K (Jun 4, 2013)8-K (May 24, 2013)8-K (Apr 30, 2013)8-K (Apr 1, 2013)8-K (Mar 21, 2013)8-K (Mar 18, 2013)8-K (Mar 11, 2013)8-K (Feb 12, 2013)8-K (Feb 8, 2013)8-K (Feb 5, 2013)8-K (Jan 25, 2013)8-K (Dec 18, 2012)8-K (Dec 7, 2012)8-K (Nov 29, 2012)8-K (Nov 26, 2012)8-K (Oct 30, 2012)8-K (Oct 29, 2012)8-K (Sep 24, 2012)8-K (Sep 10, 2012)8-K (Jul 31, 2012)8-K (Jul 26, 2012)8-K (Jun 28, 2012)8-K (Jun 20, 2012)8-K (Jun 19, 2012)8-K (Jun 12, 2012)8-K (May 25, 2012)8-K (May 24, 2012)8-K (Apr 26, 2012)8-K (Apr 25, 2012)8-K (Apr 19, 2012)8-K (Mar 7, 2012)8-K (Mar 6, 2012)8-K (Mar 5, 2012)8-K (Feb 21, 2012)8-K (Feb 2, 2012)8-K (Dec 2, 2011)8-K (Nov 30, 2011)8-K (Nov 29, 2011)8-K (Nov 1, 2011)8-K (Oct 27, 2011)8-K (Oct 18, 2011)8-K (Sep 27, 2011)8-K (Sep 9, 2011)8-K (Aug 19, 2011)8-K (Jul 28, 2011)8-K (Jun 21, 2011)8-K (Jun 13, 2011)8-K (Jun 2, 2011)8-K (May 20, 2011)8-K (Apr 27, 2011)8-K (Apr 20, 2011)8-K (Apr 19, 2011)8-K (Apr 18, 2011)8-K (Mar 18, 2011)8-K (Mar 1, 2011)8-K (Feb 14, 2011)8-K (Feb 10, 2011)8-K (Feb 9, 2011)8-K (Jan 4, 2011)8-K (Dec 27, 2010)8-K (Dec 13, 2010)8-K (Nov 1, 2010)8-K (Oct 28, 2010)8-K (Oct 26, 2010)8-K (Oct 1, 2010)8-K (Sep 21, 2010)8-K (Sep 14, 2010)8-K (Jul 28, 2010)8-K (Jul 26, 2010)8-K (Jul 22, 2010)8-K (May 27, 2010)8-K (May 24, 2010)8-K (May 18, 2010)8-K (Apr 29, 2010)8-K (Apr 28, 2010)8-K (Mar 19, 2010)8-K (Mar 16, 2010)8-K (Mar 10, 2010)8-K (Feb 26, 2010)8-K (Feb 23, 2010)8-K (Feb 3, 2010)8-K (Jan 27, 2010)8-K (Jan 25, 2010)8-K (Jan 11, 2010)8-K (Dec 11, 2009)8-K (Dec 9, 2009)8-K (Dec 7, 2009)8-K (Nov 19, 2009)8-K (Nov 17, 2009)8-K (Nov 9, 2009)8-K (Nov 6, 2009)8-K (Oct 28, 2009)8-K (Sep 15, 2009)8-K (Aug 31, 2009)8-K (Jul 29, 2009)8-K (Jul 7, 2009)8-K (Jun 18, 2009)8-K (Jun 2, 2009)8-K (Jun 1, 2009)8-K (May 26, 2009)8-K (May 19, 2009)8-K (May 7, 2009)8-K (Apr 30, 2009)8-K (Apr 22, 2009)8-K (Apr 20, 2009)8-K (Mar 30, 2009)8-K (Mar 4, 2009)8-K (Mar 2, 2009)8-K (Feb 25, 2009)8-K (Feb 19, 2009)8-K (Feb 10, 2009)8-K (Jan 12, 2009)8-K (Jan 7, 2009)8-K (Dec 23, 2008)8-K (Dec 18, 2008)8-K (Dec 12, 2008)8-K (Dec 8, 2008)8-K (Nov 10, 2008)8-K (Oct 30, 2008)8-K (Oct 23, 2008)8-K (Oct 20, 2008)8-K (Sep 24, 2008)8-K (Sep 16, 2008)8-K (Sep 8, 2008)8-K (Sep 5, 2008)8-K (Sep 2, 2008)8-K (Aug 27, 2008)8-K (Jul 31, 2008)8-K (Jun 30, 2008)8-K (Jun 25, 2008)8-K (Jun 20, 2008)8-K (Jun 16, 2008)8-K (Jun 13, 2008)8-K (Jun 3, 2008)8-K (May 29, 2008)8-K (May 16, 2008)8-K (Apr 29, 2008)8-K (Apr 17, 2008)8-K (Apr 16, 2008)8-K (Apr 2, 2008)8-K (Mar 31, 2008)8-K (Mar 24, 2008)8-K (Mar 4, 2008)8-K (Jan 31, 2008)8-K (Dec 31, 2007)8-K (Dec 10, 2007)8-K (Dec 3, 2007)8-K (Oct 31, 2007)8-K (Oct 23, 2007)8-K (Oct 15, 2007)8-K (Sep 18, 2007)8-K (Aug 29, 2007)8-K (Aug 14, 2007)8-K (Jul 31, 2007)8-K (Jun 28, 2007)8-K (Jun 19, 2007)8-K (Jun 4, 2007)8-K (May 21, 2007)8-K (Apr 26, 2007)8-K (Apr 12, 2007)8-K (Mar 20, 2007)8-K (Jan 31, 2007)8-K (Jan 22, 2007)8-K (Jan 3, 2007)8-K (Dec 20, 2006)8-K (Dec 12, 2006)8-K (Dec 7, 2006)8-K (Dec 1, 2006)8-K (Nov 27, 2006)8-K (Nov 15, 2006)8-K (Nov 13, 2006)8-K (Oct 26, 2006)8-K (Oct 2, 2006)8-K (Sep 13, 2006)8-K (Aug 23, 2006)8-K (Jul 27, 2006)8-K (Jun 29, 2006)8-K (Jun 19, 2006)8-K (Jun 7, 2006)8-K (Apr 27, 2006)8-K (Mar 30, 2006)8-K (Mar 22, 2006)8-K (Mar 7, 2006)8-K (Feb 10, 2006)8-K (Jan 31, 2006)8-K (Jan 20, 2006)8-K (Jan 18, 2006)8-K (Dec 14, 2005)8-K (Dec 13, 2005)8-K (Dec 12, 2005)8-K (Dec 5, 2005)8-K (Nov 2, 2005)8-K (Oct 26, 2005)8-K (Oct 19, 2005)8-K (Sep 27, 2005)8-K (Aug 24, 2005)8-K (Jul 27, 2005)8-K (Apr 27, 2005)8-K (Apr 6, 2005)8-K (Mar 30, 2005)8-K (Mar 28, 2005)8-K (Feb 7, 2005)8-K (Feb 3, 2005)8-K (Jan 6, 2005)8-K (Oct 21, 2004)8-K (Sep 21, 2004)8-K (Sep 10, 2004)8-K (Sep 8, 2004)8-K (Jul 28, 2004)8-K (Jun 16, 2004)

Other

Cytokinetics 8-K 2017

Documents found in this filing:

Cytokinetics, Incorporated (Form: 8-K)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of Earliest Event Reported):		February 16, 2017

Cytokinetics, Incorporated
__________________________________________
(Exact name of registrant as specified in its charter)


Delaware	000-50633	94-3291317
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)

280 East Grand Avenue, South San Francisco, California		94080
_________________________________ (Address of principal executive offices)		___________ (Zip Code)


Registrant’s telephone number, including area code:		(650) 624 - 3000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 2.02 Results of Operations and Financial Condition.

On February 16, 2017, Cytokinetics, Incorporated issued a press release announcing its results for the fourth quarter ended December 31, 2016. A copy of the press release is being filed as Exhibit 99.1 to this Current Report and is hereby incorporated by reference into this item 2.02.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following Exhibits are filed as part of this Current Report on Form 8-K:

Exhibit No. Description
----------------------------------
99.1 Press Release, dated February 16, 2017

Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	Cytokinetics, Incorporated

February 16, 2017	By:	/s/ Sharon Barbari

		Name: Sharon Barbari
		Title: Executive Vice President, Finance and Chief Financial Officer

Top of the Form

Exhibit Index


Exhibit No.		Description

99.1		Press Release, dated February 16, 2017

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Cytokinetics (CYTK)

Annual Reports

Quarterly Reports

8-K

Other

Documents found in this filing: